Warning: There are an increasing number of fraudulent websites that impersonate ECCMID. We would like to alert all our members and delegates to possible scams and we strongly advise you to use only the official ECCMID online registration for your bookings.

Abstract Guidelines

Regular abstract submission: 17 October - 30 November 2022, 16:00 CET


Submission of an abstract for ECCMID 2023 indicates your consent for the abstract to be available within the congress literature (electronic and in print). The submitted abstract should be based on novel data that has not been previously presented or published. The ECCMID Programme Committee reserves the right to reject the presentation of abstract material at ECCMID 2023 if the same data have been published in an international journal earlier than six weeks before the congress.


If the abstract materials have been submitted for publication, accepted, and published in a scientific journal between ECCMID abstract submission and the congress, we expect authors to ensure that data presented during the congress is updated or new angles are presented to avoid redundancies and duplications of already published information.


NOTE: this rule does not apply to posted pre-prints.      


Abstract quick start guide

Before submitting the abstract to ECCMID 2023, please read the guide explaining step-by-step how to navigate the submission process. In case you do not find the answer to your specific question regarding submission, please contact us at eccmidabstracts[at]escmid.org.


Abstract type

Abstracts should fall into one of four selectable categories:


  1. Regular abstract
  2. Case report/series
  3. CGR cases
  4. TAE Research Bites


If ‘Case report/ series’ or ’CGR cases’ is selected, the template sections:

Background/Materials/Results/ Conclusions will be automatically replaced by the sections:

Background/Case(s) description/ Discussion



If the submitter is a co-author of the abstract, we kindly ask you to include this information on the co-author list.

Please double check correct spelling and formatting of the author(s) names and affiliation(s).

Please use appropriate capitalisation and punctuation.             

Please note that the submitter cannot edit names and affiliations once the submission is completed.


ESCMID takes no responsibility for errors in either author or affiliation information.



ALL CAPS for text (other than abbreviations or acronyms) are not allowed. The abstract text cannot be longer than 350 words.



Abstract title should be concise and must be submitted in line with scientific rules. This applies to special characters and words that need to be CAPITALISED or italicised.


Please DO NOT capitalise title except first word, DO NOT use a dot to finish title.

Please DO NOT use any brand names in the title. ESCMID reserves rights to proof and adjust titles according to ESCMID guidelines format without consent of the author


Abstract body

Use the provided fields to draft your abstract. The text of the entire abstract must not exceed 350 words (excluding title and figure descriptions). Please ensure that different sections of your abstract are entered into the appropriate textbox. For research abstracts, briefly state the background, context of research, and its goals.


The methods section should provide minimum required information on the research setting, data collection, and analytical methods.


The results presented in the abstract should be original, not published or presented previously.

For case report/series and CGR cases (usually featuring a single instructive case or a series of up to 10 cases) emphasise the unique aspects of the case and discuss the learning points emerging from the case(s).

Reviews only or abstracts without data content cannot be accepted.



Please use the figure upload fields at the bottom to select up to 3 images. Figure sections can be used to upload images, graphs, or tables.


Accepted formats: JPEG or PNG. Size: 1000x1000 pixels max. File size: up to 5 MB. Images larger than provided dimensions will be automatically resized to an A4 format in your submission confirmation.


Please double-check the readability of uploaded materials before submitting your abstract.


Spelling guidelines

Use British English spelling throughout. The International System of Units (SI) should be used wherever appropriate. Genus and species names should be written in full as the first mentioned and abbreviated subsequently.


The following scientific rules apply (examples in brackets):


  • Systematic names (genus, family, and higher orders): capitalized (e.g., Chlamydia, Enterobacterales Picornaviridae)
  • Non-English expressions in English texts are written in italics (e.g., in vitro/in vivo, ad hoc, ex officio)
  • Taxonomic names must be italicised (e.g., Staphylococcus aureus, Clostridium difficile)
  • Non-systematic names (e.g., plural): lower case and not italicized (group A streptococci, mycobacteria)
  • Generic drug names: lower case (e.g, penicillin)
  • Do not use brand names in titles: product names are allowed in the abstract text, but must be avoided in the title
  • Please follow standard English grammar rules including a space after full stops and commas
  • Only common abbreviations may be used without definition

Abstract topics

The full list of abstract topics may be found here.

Please choose the best-fitting abstract topic to ensure a sound and fair review by the most suitable reviewing expert.

It is possible (but not mandatory), specify a second category, if you feel that your abstract does not fit within a single category.

All case and case series abstracts will be automatically assigned to the category 13. Cases


Authors are asked to enter three keywords to better define the abstract content.

Submit your abstract

You can save your abstract at any time. Please make sure to fill all fields correctly before final submission. Changes in the abstract are not possible after submission. After submission, a confirmation by email will be sent to the submitter (please make sure to state your correct email address!). All co-authors will be notified by email and will receive a copy of the submitted abstract. The submitter is responsible for obtaining permission for submission and presentation of the abstract from all co-authors and any relevant stakeholders. All correspondence regarding acceptance or rejection, including further information on the mode of presentation etc. will be sent to the presenting author. In case an abstract will be rejected as an oral presentation, its possibility to be accepted as a poster still remains. If so, the authors will be informed via e-mail.


Should you decide to change the type of abstract once you have started the submission, please withdraw your current abstract and re-start the submission process with new content.





Please ensure that all author names are correct upon submission. It is the responsibility of the presenting author to ensure that this is kept up to date, in case of changes. Following ECCMID, a certificate of presentation will be sent to the presenting author only. The presenting author is then responsible for disseminating this certificate amongst any co-authors.


Certificates will not be awarded to authors that are not present during their poster session at ECCMID, or whose posters do not comply with the requirements for size and format. For those with an oral presentation, the presentation slides must be uploaded to the online system by the specified deadline, as well as presented, in order for a certificate to be awarded.


If you have any questions or need any assistance, please do not hesitate to contact us at eccmidabstracts[at]escmid.org.